Colgate-Palmolive Company (CL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 3,049,000 | 2,455,000 | 1,967,000 | 2,338,000 | 2,860,000 |
| Depreciation Amortization | 605,000 | 567,000 | 1,266,000 | 1,127,000 | 539,000 |
| Income taxes - deferred | -77,000 | -98,000 | -78,000 | -132,000 | -120,000 |
| Accounts receivable | -56,000 | -37,000 | -227,000 | -84,000 | 138,000 |
| Other Working Capital | 344,000 | 455,000 | -726,000 | -197,000 | 381,000 |
| Other Operating Activity | 242,000 | 403,000 | 354,000 | 273,000 | -79,000 |
| Operating Cash Flow | $4,107,000 | $3,745,000 | $2,556,000 | $3,325,000 | $3,719,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -10,000 | -4,000 | -148,000 | 0 | -19,000 |
| PPE Investments | -561,000 | -705,000 | -649,000 | -567,000 | -410,000 |
| Net Acquisitions | N/A | N/A | -809,000 | N/A | -353,000 |
| Other Investing Activity | 37,000 | -33,000 | 5,000 | -25,000 | 3,000 |
| Investing Cash Flow | $-534,000 | $-742,000 | $-1,601,000 | $-592,000 | $-779,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 93,000 | -906,000 | 540,000 | -171,000 | 488,000 |
| Debt Issued | 2,000 | 1,495,000 | 1,513,000 | 699,000 | 0 |
| Debt Repayment | -503,000 | -903,000 | -406,000 | -703,000 | -1,085,000 |
| Common Stock Issued | 638,000 | 380,000 | 418,000 | 424,000 | 874,000 |
| Common Stock Repurchased | -1,739,000 | -1,128,000 | -1,308,000 | -1,320,000 | -1,476,000 |
| Dividend Paid | -1,789,000 | -1,749,000 | -1,691,000 | -1,679,000 | -1,654,000 |
| Other Financing Activity | -91,000 | 18,000 | -18,000 | -24,000 | -66,000 |
| Financing Cash Flow | $-3,389,000 | $-2,793,000 | $-952,000 | $-2,774,000 | $-2,919,000 |
| Exchange Rate Effect | -54,000 | -19,000 | -60,000 | -15,000 | -16,000 |
| Beginning Cash Position | 966,000 | 775,000 | 832,000 | 888,000 | 883,000 |
| End Cash Position | 1,096,000 | 966,000 | 775,000 | 832,000 | 888,000 |
| Net Cash Flow | $130,000 | $191,000 | $-57,000 | $-56,000 | $5,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 4,107,000 | 3,745,000 | 2,556,000 | 3,325,000 | 3,719,000 |
| Capital Expenditure | -561,000 | -705,000 | -696,000 | -567,000 | -410,000 |
| Free Cash Flow | 3,546,000 | 3,040,000 | 1,860,000 | 2,758,000 | 3,309,000 |